Chair Welcome
Thank you for your interest in the Neurology Residency Program at the University of Rochester. The University of Rochester Medical Center has a long tradition of excellence in education, patient care, and research. The major divisions and programs in the Department include: The Neuromuscular Disease Center, Behavioral Neurology, the Strong Epilepsy Program, the Stroke Program, Movement and Inherited Neurological Disorders, Child Neurology, Neuroimmunology (MS), Neuro-ophthalmology, Sensory Motor Neurology, the Clinical Trials Coordination Center, and the Experimental Therapeutics Program, the Alzheimer's Disease Center, and the Stem Cell and Gene Therapy Program. Department programs are housed in a 6,200 NSF modern office and data analysis space and over 23,000 NSF of modernized laboratory space. In the last several years, two research buildings were opened at the Medical Center to house the Rochester Institute of Biological Sciences (240,000 square feet). Department neuroscientist, Steven Goldman, M.D., Ph.D., is Director of the Neurology Department's Stem Cell and Gene Therapy Program, and Co-directs the new Center for Translational Neuromedicine. Over 20 other neuroscientists are in this new facility. Pediatric Neurologist, Harris Gelbard, M.D., Ph.D. is Interim Director of the Center for Neural Development and Disease. A new Clinical Translational Science Building is in the final stages of planning and will open in 2009. Many Neurology faculty will move into this new building. Department subspecialty units all have major clinical programs with a regional or national/international referral base. Each unit has access to clinical space including a newly renovated (September 2007) 5,000 NSF outpatient facility of the Neurology Department, which has examining rooms and adjacent clinical electrophysiology laboratories. In addition, there are four examination rooms dedicated to clinical trials and housed within the Clinical Trials Coordination Center. The inpatient and outpatient facilities of the General Clinical Research Center are available. The Neurology Department is the major institutional user of GCRC research space. The University of Rochester Department of Neurology has developed steadily over the past two decades. Since 1986 the Department has grown from 22 to over 100 full-time faculty members. In 2008, extramural research support totaled approximately $25 million. Additional major strength in neuroscience is present in the Departments of Brain and Cognitive Sciences, Neurosurgery, Neurobiology and Anatomy, Ophthalmology, Pharmacology and Physiology, The Center for Visual Science, and the Center for Translational Neuromedicine. The Department has a strong focus on Experimental Therapeutics: Developing new treatments for neurological diseases. The University of Rochester Department of Neurology is home to many international disease study groups including the Parkinson's Study Group, Huntington Disease Study Group, Tourette Syndrome Study Group, Myasthenia Study Group, and the Multiple Sclerosis Core. The department's NINDS-funded Fellowship program is Experimental Therapeutics of Neurological Disease has trained over 50 academic clinical neuroscientists for careers in patient-oriented and translational disease. Richard T. Moxley, III , M.D.
|
